ESC Premium Access

DECAAF II: efficacy of DE-MRI-guided fibrosis ablation vs. conventional catheter ablation of persistent atrial fibrillation

Congress Session

About the speaker

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)
22 presentations
0 follower

2 more presentations in this session

DECAAF II - Discussant review.

Speaker: Professor C. Leclercq (Rennes, FR)

Thumbnail

DECAAF II: efficacy of DE-MRI-guided fibrosis ablation vs. conventional catheter ablation of persistent atrial fibrillation - Panel discussion.

Thumbnail

Access the full session

Hot Line - DECAAF II

Speakers: Professor N. Marrouche, Professor C. Leclercq
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

One-month DAPT in stable coronary artery disease

27 August 2021

ESC Premium Access

EmDia - Empagliflozin and left ventricular diastolic function

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

This platform is supported by

logo Novo Nordisk